Trial Summary
What is the purpose of this trial?
Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present multicenter study (conducted through the Exposure Therapy Consortium) is designed to evaluate whether trait versus state positive affectivity is a more effective predictor of exposure therapy outcomes. Further, the investigators will examine whether the predictive significance of trait positive affectivity can be accounted for by examination of baseline levels of self-efficacy, hope, and optimism.
Research Team
Michael Otto, PhD
Principal Investigator
Boston University
Eligibility Criteria
This trial is for individuals with anxiety disorders, specifically those who experience speech anxiety or social anxiety disorder. Participants should be comfortable using virtual reality (VR) technology as the intervention involves a single-session VR exposure.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Single-session VR exposure intervention (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University Charles River Campus
Lead Sponsor
The University of Hong Kong
Collaborator
University of Texas at Austin
Collaborator
Tufts University
Collaborator
The University of New South Wales
Collaborator
Curtin University
Collaborator
Erasmus University Rotterdam
Collaborator
University of Western Sydney
Collaborator
National University of Singapore
Collaborator
Philipps Universität Marburg
Collaborator